V Square Quantitative Management LLC Invests $1.65 Million in Cigna Group $CI

V Square Quantitative Management LLC bought a new stake in Cigna Group (NYSE:CI) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 6,011 shares of the health services provider’s stock, valued at approximately $1,654,000.

Several other institutional investors also recently modified their holdings of the business. Capital Research Global Investors grew its holdings in Cigna Group by 140.2% during the third quarter. Capital Research Global Investors now owns 3,179,301 shares of the health services provider’s stock valued at $916,434,000 after purchasing an additional 1,855,897 shares during the period. Ameriprise Financial Inc. grew its holdings in Cigna Group by 54.5% during the third quarter. Ameriprise Financial Inc. now owns 2,136,311 shares of the health services provider’s stock valued at $615,781,000 after purchasing an additional 753,865 shares during the period. Balyasny Asset Management L.P. grew its holdings in Cigna Group by 1,057.2% during the second quarter. Balyasny Asset Management L.P. now owns 404,753 shares of the health services provider’s stock valued at $133,803,000 after purchasing an additional 369,775 shares during the period. Man Group plc grew its holdings in Cigna Group by 215.5% during the second quarter. Man Group plc now owns 532,183 shares of the health services provider’s stock valued at $175,929,000 after purchasing an additional 363,510 shares during the period. Finally, Dodge & Cox grew its holdings in Cigna Group by 4.0% during the third quarter. Dodge & Cox now owns 9,305,225 shares of the health services provider’s stock valued at $2,682,231,000 after purchasing an additional 354,615 shares during the period. 86.99% of the stock is owned by institutional investors.

Insider Activity

In other news, insider Nicole S. Jones sold 2,307 shares of Cigna Group stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $666,515.37. Following the transaction, the insider owned 32,647 shares in the company, valued at approximately $9,432,044.77. The trade was a 6.60% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Everett Neville sold 1,719 shares of Cigna Group stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $496,636.29. Following the completion of the transaction, the insider owned 5,670 shares in the company, valued at approximately $1,638,119.70. This represents a 23.26% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.60% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on CI. Barclays cut their price target on Cigna Group from $305.00 to $303.00 and set an “overweight” rating for the company in a report on Friday, February 6th. Guggenheim reiterated a “buy” rating and issued a $318.00 price objective on shares of Cigna Group in a research report on Monday, February 2nd. Deutsche Bank Aktiengesellschaft increased their price objective on Cigna Group from $301.00 to $304.00 and gave the stock a “buy” rating in a research report on Tuesday, February 10th. Royal Bank Of Canada lowered their price objective on Cigna Group from $344.00 to $333.00 and set an “outperform” rating on the stock in a research report on Friday, February 6th. Finally, Piper Sandler lowered their price objective on Cigna Group from $374.00 to $370.00 and set an “overweight” rating on the stock in a research report on Tuesday, March 3rd. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $333.11.

Cigna Group Stock Up 1.2%

CI opened at $277.52 on Thursday. The company has a market cap of $73.13 billion, a P/E ratio of 12.51, a P/E/G ratio of 0.94 and a beta of 0.26. The business’s 50-day moving average price is $276.26 and its 200-day moving average price is $278.75. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 0.74. Cigna Group has a 12 month low of $239.51 and a 12 month high of $350.00.

Cigna Group (NYSE:CI) last released its quarterly earnings data on Thursday, February 5th. The health services provider reported $8.08 EPS for the quarter, topping the consensus estimate of $7.88 by $0.20. The firm had revenue of $72.50 billion for the quarter, compared to the consensus estimate of $69.53 billion. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.The company’s quarterly revenue was up 10.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $6.64 earnings per share. Cigna Group has set its FY 2026 guidance at 30.250- EPS. On average, equities analysts expect that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, March 19th. Stockholders of record on Thursday, March 5th were issued a $1.56 dividend. This is an increase from Cigna Group’s previous quarterly dividend of $1.51. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. The ex-dividend date was Thursday, March 5th. Cigna Group’s dividend payout ratio (DPR) is presently 28.13%.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.